We studied 19 
Introduction
Adrenoleukodystrophy (ALD) is a peroxisomal disorder percentage of women with neurological involvement rises from 16% to 53% (Moser et al., 1991) . Biochemical assays caused by an abnormal gene localized in the Xq28 area (Moser and Moser, 1989) . The biochemical abnormality is can also disclose the carrier status in asymptomatic women (O'Neill et al., 1984) , but it is still impossible to predict characterized by the accumulation of very-long-chain fatty acids. Clinical features are extremely variable, ranging from whether a carrier will develop clinical problems. A recent study of X inactivation showed no evidence that skewed the severe cerebral symptoms of the childhood form to the gradually progressive adult spinal form (adrenomyelopatterns are related to clinical manifestations (Watkiss et al., 1993) ; however, there are obvious difficulties in the standard neuropathy, AMN). Female carriers may also develop neurological signs in adult life; paraparesis and sensory loss in utilization of genetic studies. It is therefore of the utmost importance to find an objective marker of subclinical involvelower limbs are the most common findings, but, taking into account minor neurological signs and symptoms, the ment in asymptomatic cases. In recent years, dietary treatment (administration of oleic and erucic acids) has been proposed showed objective signs of mild or advanced neurological involvement (28%). Nineteen unselected patients (mean age, as a possible therapy for ALD, but no relevant clinical benefit has been found in either ALD or in adult AMN patients 45Ϯ11 years; range, 18-68 years) agreed to undergo further studies. The study had the approval of the Ethical Committee (Uziel et al., 1990; Moser et al., 1992; Aubourg et al., 1993; Kaplan et al., 1993) , despite a clear reduction in the plasma of the Universitá Cattolica del S. Cuore, and all patients gave their informed consent according to the declaration of level of very-long-chain fatty acids. Since clinically evident demyelination in ALD/AMN is probably caused by secondary Helsinki. Of these patients, 14 had normal neurological examination (grade 0), two had mild abnormalities without inflammatory mechanisms (Powers et al., 1992; Powers, 1995) , correction of the biochemical defect could be more disability (grade 1), three had clear neurological signs with functional deficit (grade 2). Brain MRI was performed in 17 effective in preventing than in relieving neurological signs (Moser, 1995) . The finding of subclinical signs of neurological out of the 19 patients on a superconducting 0.5 tesla unit, using multiplanar spin-echo, fast spin-echo and inversion involvement in carriers might therefore be important in evaluating the need as well as the effectiveness of dietary recovery sequences. Very-long-chain fatty acids determination was obtained treatment. MRI can detect early lesions of the cerebral white matter in AMN patients (Aubourg et al., 1992) , but it is from plasma samples, by using the method of Di Biase et al. (1995) . rarely abnormal in asymptomatic carriers (Kumar et al., 1995) . Evoked potential studies have proved useful in disclosing subclinical abnormalities in ALD carriers, but they have not been performed in large groups (Moloney and 
SEP recording procedure
For SEP recording, patients lay on a couch in a warm and Masterson, 1982; Garg et al., 1983; Tobimatsu et al., 1985) . Moreover, despite their proven usefulness in disclosing subsemidarkened room. Stimuli (0.3-ms duration, 5 Hz) were delivered by skin electrodes at the wrist for the median nerve, clinical abnormalities of the pyramidal tracts (Ugawa et al., 1988) that are more frequently involved in female ALD and at the ankle for the tibial nerve; stimulus intensity was adjusted to slightly above the motor threshold. The filter carriers (O' Neill et al., 1984; Moser and Moser, 1989) , motor evoked potentials (MEPs) have so far been studied bandpass was 30-3000 Hz (-3 dB at cut-off point, 6 dB per octave). Responses were averaged with a bin width of 98 µs in only one carrier (Kukowski, 1991) . Finally, previous somatosensory evoked potential (SEP) studies in ALD carriers over a total analysis time of 50 ms, including 2.5 ms of preanalysis for median-nerve SEPs, and with a bin width of 196 did not utilize non-cephalic recording techniques, which permit a more precise localization of the somatosensory µs over a total analysis time of 100 ms, including 5 ms of pre-analysis for tibial-nerve SEPs. Samples with excessive dysfunction (Desmedt and Cheron, 1982) . The aim of the present study was to test the effectiveness of MEPs and noninterference were automatically edited out of the average. Two averages of 2048 trials each were obtained and printed cephalic SEPs, as well as brain MRI, in revealing neurological abnormalities in a population of 19 female carriers.
out by the computer on a desk-jet printer. For median-nerve SEP recording, electrodes were placed in the supraclavicular fossa (Erb's point), over the sixth cervical vertebra, and in parietal scalp regions contralateral
Subjects and methods
and ipsilateral to the stimulated side. The Erb's point electrode was referred to Fz; the cervical electrode was referred to an
Preliminary clinical study
This study has been preceded by the clinical examination of electrode located immediately above the thyroid cartilage; scalp electrodes were referred to the shoulder contralateral a population of 39 female carriers, all of whom had a family history of ALD (34 had sons with AMN or ALD, and five to the stimulated side (non-cephalic reference). Non-cephalic scalp recordings allowed us to record the subcortical far-field were relatives of obligate carriers (mean age, 50 Ϯ 11 years; range, 34-70 years). All 39 subjects had abnormally high P14 potential (Desmedt and Cheron, 1982) . For tibial nerve SEP recording, electrodes were placed over the fourth lumbar plasma levels of very-long-chain fatty acids. A standardized neurological examination including pyramidal, sensory, cerevertebra (referred to the second lumbar vertebra), over the twelfth dorsal vertebra (referred to an electrode located bellar, bladder and cerebral function and motor peripheral nerve function was performed. After this preliminary study, all immediately above the umbilicus) and at CzЈ, 2 cm behind Cz, (referred to Fz). carriers were classified following three scores of neurological involvement: grade 0 ϭ neither complaints nor objective Normative data for median nerve SEPs were obtained from 46 healthy subjects, 18 male and 28 female (mean age, 35.4 neurological symptoms (n ϭ 28); grade 1 ϭ mild abnormalities at the neurological examination without disability, usually years; range, 18-62 years) (Restuccia et al., 1992) ; we evaluated peak latencies of Erb's point N9, cervical N13, hyper-reflexia or mild vibratory sensation impairment in lower extremities (n ϭ 5); grade 2 ϭ abnormalities at the scalp far-fields P9 and P14 and contralateral scalp N20. We also calculated P9-P14 and P14-N20 interpeak intervals, in neurological examination (paraparesis, sensory loss, mental disturbances) with varying degrees of disability (n ϭ 6).
order to evaluate separately the somatosensory conduction along the posterior cervical columns and the intracranial Therefore, we found in our series that 11 out of the 39 women pathways (Desmedt and Cheron, 1980) . Finally, to evaluate flow, as viewed from above, was used for the right motor cortex and an anti-clockwise flow for the left motor cortex amplitude abnormalities in the spinal N13 and in the scalp P14 waves, we evaluated the N13/P9 and P9/P14 amplitude (Day et al., 1990) . Cortical stimulation was performed first with the target muscle relaxed and then during a slight ratios (Garcia-Larrea and Mauguière, 1988; Restuccia and Mauguière, 1991) . Normative data for tibial nerve SEPs were voluntary contraction. Cortical stimulation was performed during voluntary contraction of about 20% of maximum obtained from 35 healthy subjects, 16 male and 19 female (mean age, 32 years; range, 19-59 years) (Restuccia et al., voluntary contraction of the tested muscle in order to facilitate the responses, since MEP size increases and its 1993). We evaluated peak latencies of the cauda equina response recorded at L4, of the spinal N24 recorded at T12, latency shortens when the muscle is voluntarily contracted (Hess et al., 1987) . Compound muscle action potentials and of the scalp P40 response. We also calculated the cauda equina-P40 interpeak interval, to avoid excessive dispersion were recorded from thenar and tibialis anterior muscles by surface electrodes and amplified with filter settings of 2 Hz of data due to inter-individual variations related to subject's height. Normative data for upper and lower limb stimulation and 5 kHz. To evaluate the peripheral motor conduction from the spinal cord to the muscles, magnetic stimulation was are summarized in Table 1. performed on the cervical and lumbar spines. For radicular stimulation, the lower edge of the coil was placed just lateral to C7-D1 and L4-L5 spinous processes for thenar and tibialis
MEP recording procedure
During magnetic stimulation the patients were seated in anterior muscles, respectively. A clockwise inducing current, as viewed from behind, was used for the right muscles and a reclining chair. Transcutaneous magnetic stimulation of the motor cortex was achieved using a Magstim 200 anticlockwise for the left muscles. The stimulus intensity was 60% of maximal output. Central motor conduction time (Novametrix). The magnetic pulse was delivered through a magnetic coil. The stimulus intensity was 100% of the (CMCT) to upper and lower limb myotomes was evaluated by subtracting the latency after cervical or lumbar stimulation maximal output for cortical stimulation. The maximal magnetic field generated was~2 T at the centre of the coil.
from the latency after cortical stimulation during voluntary contraction of the target muscles. Control values for the The coil was centred on the vertex. To obtain preferential activation of each hemisphere, a clockwise inducing current latency of compound muscle action potentials after cortical * SEP (somatosensory evoked potential) patterns: 1 ϭ only tibial nerve abnormalities; 2 ϭ tibial nerve and median nerve P14 abnormalities; 3 ϭ tibial nerve abnormalities and median nerve P14 and P14-N20 interval abnormalities. † MEP (motor evoked potential) patterns: ϩ ϭ lower limb CMCT (central motor conduction time) abnormalities; ϩϩ ϭ upper and lower limb CMCT abnormalities. ‡ VLCFA ϭ verylong-chain fatty acids (normal value for C24/C22 Ͻ 1, normal value for C26:0 Ͻ 0.6).
and radicular stimulation and for CMCT were obtained after Erb's point response after median nerve stimulation) were bilateral studies on 25 healthy subjects, 13 male and 12 always within normal limits, except in Subject 15 (who female (mean age, 43.7 years; SD, 18) and are summarized showed a slight latency delay of both potentials) and Subject in Table 1. 18 (in whom the cauda equina response after tibial nerve stimulation was bilaterally absent). Central somatosensory conduction after tibial nerve stimulation was abnormal in 12
Results

out of 19 subjects (8-19). CNS responses after median
Clinical, MRI and biochemical findings nerve stimulation were abnormal in 10 out of 19 patients. In MRI and clinical findings and plasma very-long-chain fatty detail, median nerve SEPs showed: (i) an abnormal N13 acids values are summarized in Table 2 . Clinical examination cervical response in seven subjects (12-15 and 17-19); (ii) was abnormal in five patients (15) (16) (17) (18) (19) . Levels of very-longan abnormal P14 subcortical potential in 10 subjects (nos. chain fatty acids were abnormally high in all subjects. All 10-19); (iii) an abnormal N20 scalp response, with the of them displayed normal adrenal function, while two showed P14-N20 interval increased, in three subjects (14, 18 and 19). signs of autoimmune thyroiditis. Proton density and T 2 -By combining the results obtained from median and tibial weighted images revealed small focal areas of hyperintensity nerve stimulation, we were able to recognize three different in two patients (14 and 19). In the first patient they were patterns of SEP abnormality in the 12 subjects who showed localized in the paratrigonal white matter. In the second neurophysiological signs of central somatosensory dysfuncpatient demyelinating lesions were localized in the left tion. (i) Pattern 1 (abnormal tibial nerve SEPs, fully normal paratrigonal white matter and in the right putamen. Enlargemedian nerve SEPs): two subjects (8 and 9). (ii) Pattern 2 ment of subarachnoid spaces was noticed in four patients (abnormal tibial nerve SEPs, abnormal P14 potential after (15, 16, 17 and 18). Brain MRI was completely normal in median nerve stimulation): eight subjects (10-17). In five of the remaining subjects.
these subjects (12, 13, 14, 15, 17) , the cervical N13 response was also abnormal. This pattern is illustrated in Fig. 1 . (iii) Pattern 3 (abnormal tibial nerve SEPs, abnormal P14 potential
Evoked potential findings
and P14-N20 interval after median nerve stimulation): two SEP findings are summarized in Table 3 . Peripheral responses (cauda equina response after tibial nerve stimulation and subjects (18 and 19). In both subjects, the cervical N13 response was also abnormal. This pattern is illustrated in motor pathways, since the latency of the muscle response after spinal stimulation was always within normal limits. Fig. 2 .
The MEP study did not reveal any abnormality in peripheral CMCT to lower limbs was abnormally prolonged in eight subjects (8 and 13-19); in two of them (13 and 19), the of the utmost importance to find other markers of CNS involvement in these patients, not only for theoretical, but CMCT to upper limbs was also abnormally prolonged (see Fig. 1 ).
also for practical reasons. Dietary therapy seems ineffective in advanced stages of disease (Uziel et al., 1990; Moser et al., 1992; Aubourg et al., 1993; Kaplan et al., 1993) ; on the other hand, Moser et al. (1995) reported encouraging,
Clinical-neurophysiological correlation
Clinical examination revealed slight abnormalities in two although not definitive, results in patients treated before the development of severe neurological signs. Objective signs of patients (score ϭ 1 for 15 and 16) and clear-cut neurological signs in three patients (score ϭ 2 for 17, 18 and 19). In the CNS involvement in carriers with absent or ambiguous clinical deficits might justify a long-term and expensive remaining 14 subjects the neurological examination did not reveal any abnormality (score ϭ 0). Therefore, there were dietary treatment in patients, such as female carriers, who may develop neurological deficits in adult life. no differencies between this group of patients and the total group of 39 carriers in both mean age (45Ϯ11 years versus Several factors suggest that evoked potentials can reveal subclinical abnormalities. Earlier studies in small populations 50Ϯ11 years, unpaired t test, P ϭ 0.14) and clinical features (patients without any clinical sign, 14 out of 19, 73,7%, of asymptomatic carriers have reported subclinical neurophysiological abnormalities (Moloney and Masterson, 1982 ; versus 28 out of 39, 71,7%). Seven of the 14 patients without neurological signs (score ϭ 0) showed unequivocal Garg et al., 1983; Tobimatsu et al., 1985) . However, since these studies utilized a simplified SEP recording technique, neurophysiological abnormalities. The mildest type of SEP abnormality (Pattern 1) was noticed in two patients (8 and they focused only on the severity of the nervous system involvement and not on the localization of the dysfunction. 9); Patient 8 also showed abnormal CMCT to the left lower limb. Five of these 14 patients (10-14) showed more severe Our study on a large series of carriers definitively demonstrates that SEPs are frequently abnormal in these patients; SEP abnormalities (Pattern 2); two of them (13 and 14) also had abnormal MEPs. Patients with minor clinical abnormalimoreover, our data suggest that the CNS involvement follows a definite pattern. We found three different patterns ties (score ϭ 1 for 15 and 16) always showed abnormal SEPs (Pattern 2) and abnormal MEPs. Patients with evident of abnormality, corresponding to three different degrees of central somatosensory involvement. Two women had clinical involvement (score ϭ 2 for 17, 18 and 19) showed the most severe degree of neurophysiological abnormality, abnormal tibial but normal median nerve SEPs; another 10 women showed abnormalities of both median and tibial nerve since they had abnormal SEPs (Patterns 2 and 3) and abnormal MEPs. Clinical-neurophysiological correlation is SEPs. In these 10 subjects with abnormal median nerve SEPs, our recording technique permitted us to distinguish summarized in Table 2 . Clinical scores and SEP patterns of abnormality were significantly correlated (χ 2 ϭ 15.66, clearly whether the somatosensory dysfunction was located in the intracranial somatosensory pathways or in the dorsal P ϭ 0.016).
columns. It has been demonstrated that the P14 far-field scalp response, obtained using non-cephalic reference montage, reflects the activation of the brainstem tracts of lemniscal
Discussion
Various data suggest that our sample of 19 carriers could be pathways (Desmedt and Cheron, 1982) . Abnormalities of this wave have been correlated with conduction slowing in considered as representative of the total group of unselected carriers. We did not find any difference between this group cervical dorsal columns (Yamada et al., 1986) or with demyelination in the lower brainstem (Yamada et al., 1986 ; of patients and the total group of 39 carriers in either mean age or clinical features.
Garcia-Larrea and Mauguière, 1988), whereas abnormal prolongation of the P14-N20 interval has been found in various The major finding in our study was that seven of 14 ALD carriers whose neurological examination was normal had types of intracranial lesion (Mauguière et al., 1983) . All 10 patients with abnormal median nerve SEPs showed abnormal demonstrable neurophysiological abnormalities. Although it is generally accepted that many ALD carriers can develop P14 responses; in eight patients the isolated P14 abnormality suggested a somatosensory dysfunction located below the neurological symptoms in their life, some uncertainties remain about severity and incidence of the neurological involvement.
foramen magnum, while in two patients the simultaneous abnormality of both P9-P14 and P14-N20 intervals suggested In an earlier clinical study Moser et al. (1991) clearly stated that the percentage of carriers who contact their physician that the dysfunction involved both the extracranial and intracranial somatosensory pathways. Moreover, in seven out for clear-cut neurological problems is quite low (16%). In contrast, detailed neurological examination of heterozygotes, of the 10 women with abnormal P14 waves, the cervical N13 response was also abnormal. Since this potential is performed on the occasion of their sons' periodic control examinations, revealed a neurological involvement varying thought to be generated in the dorsal horn of the lower cervical cord (Desmedt and Cheron, 1981 ; Restuccia and from definite deficits to minor neurological signs, such as hyper-reflexia or impaired sensation in lower limbs in Ͼ50% Mauguière, 1991), this finding suggests a dysfunction of the cervical grey matter in these subjects. of cases.
Since clinical signs may be mild or questionable, it is The finding of different patterns of CNS involvement in our subjects could be variously explained. To our extremely variable even among members of a single family (Moser, 1995) . A cerebral form of adult-onset ALD, less knowledge, most previously reported cases of symptomatic carriers presented a clear myelopathic syndrome, intact common than the classical AMN, has been recognized, whose clinical, neuropathological and neuroradiological adrenal function and, in only few cases, dementing illness (O'Neill et al., 1984; Moser and Moser, 1989 ; Ménage features closely resemble those of childhood ALD (Moser and Moser, 1989) . It is possible that some of our carriers et al., 1993) . Clinical features in symptomatic carriers thus resemble those in AMN, but are milder and of later onset (in particular, those presenting neurophysiological signs of intracranial involvement) show a subclinical cerebral form. (Moser and Moser, 1989) ; it is therefore conceivable, in most cases, that pathogenetic mechanisms also resemble
Of three autopsy studies of carriers so far reported, two showed pathological findings very similar to those observed those of milder and earlier forms of AMN. Whereas childhood ALD is characterized by a severe inflammatory in cerebral ALD (Molzer et al., 1981; Powers et al., 1987) , and one, of an asymptomatic women, showed myelinopathy, autopsy studies in AMN suggest degeneration of the spinal tracts, distributed in a 'dying-back' pattern, features very similar to those observed in the spinal AMN variant (Powers et al., 1987) . with segmental demyelination secondary to axon loss, and slight or absent inflammatory features (Schaumburg et al., To our knowledge, MEPs have to date been studied in one carrier only (Kukowski, 1991) . MEP recordings do 1977; Powers, 1995) . As far as the peripheral nervous system is concerned, a recent study on nerve conduction not permit such a precise localization as SEPs, but they enabled us to detect subclinical abnormalities of central in AMN patients as well as in symptomatic carriers (Chaudry et al., 1996) provided in vivo evidence of motor pathways in three out of 14 asymptomatic carriers. Our study was not expressly designed to analyse peripheral axonal loss. In some of our patients, in a stage of disease with predominant axonal loss, the almost peripheral nervous system functions. However, SEP recordings at the cauda equina and at Erb's point, as well as exclusive involvement of longer axons might explain the isolated abnormality of lower limb SEPs. In more advanced the compound muscle action potential latency after spinal magnetic stimulation, may reveal a dysfunction of the stages, segmental demyelination in the terminal tracts of the dorsal column fibres might explain the abnormality of peripheral nervous system. Latency delay of the Erb's point and cauda equina responses was observed in one the median nerve P14 response. In patients also showing abnormalities of the cervical N13 response, it is possible carrier only; this is in agreement with the clinical finding of uncommon involvement of the peripheral nervous system that the dorsal column axon loss together with segmental demyelination in the dorsal column axon endings, might in symptomatic carriers (O'Neill et al., 1984) . The low percentage of brain MRI abnormalities in our cause this N13 abnormality, probably due to deafferentation of the dorsal horn neurons generating the N13 cervical study is not surprising, since an earlier study reported only 20% MRI abnormalities in the whole ALD heterozygous response (Desmedt and Cheron, 1981; Restuccia and Mauguière, 1991) . The later occurrence of intracranial population (Kumar et al., 1995) , despite the high incidence of MRI abnormalities in male AMN patients (Aubourg demyelination could therefore correspond to the third, less common pattern, characterized by conduction disturbances et al., 1992) . The spinal nature of the neurological involvement in most ALD carriers might account for the in dorsal columns as well as in intracranial somatosensory pathways. In conclusion, it is possible that SEP abnormalihigher incidence of the spinal cord MRI abnormalities in these patients (Kumar et al., 1995) . Spinal cord MRI, ties in our patients reflect a progressive involvement of the CNS, not always detectable by MRI and clinical which was not performed in this study, could theoretically enhance the overall MRI findings in both symptomatic examinations. Indeed, neurophysiological abnormalities were significantly correlated to the clinical involvement in and asymptomatic patients. However, spinal cord atrophy revealed by MRI cannot be used easily as a marker in our subjects. Whereas seven out of the 14 asymptomatic carriers showed the milder types of SEP abnormality monitoring the disease. On the other hand, SEPs may be important not only to assess, but also to monitor the (Patterns 1 and 2) and only three showed MEP abnormalities, patients with mild or definite clinical signs always course of the disease.
In conclusion, our data suggest that SEP and MEP studies showed the most severe SEP findings (Pattern 2 or 3) and clear-cut MEP abnormalities.
in asymptomatic carriers might provide an assessment of subclinical neurological involvement. Moreover, in the That in our series the mean age of the neurologically uninvolved women (Patients 1-7) is less than the mean whole population of ALD carriers, neurophysiological assessment could be helpful in selecting patients for age of patients showing both clinical and neurophysiological abnormalities , lends further substance to experimental treatments and in monitoring their efficacy. our hypothesis of progressive involvement of the CNS. However, it is also hypotesizable that the different neurophysiological patterns of abnormality observed in our
